Welcome to LookChem.com Sign In|Join Free

CAS

  • or

92817-88-4

Post Buying Request

92817-88-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

92817-88-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 92817-88-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,2,8,1 and 7 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 92817-88:
(7*9)+(6*2)+(5*8)+(4*1)+(3*7)+(2*8)+(1*8)=164
164 % 10 = 4
So 92817-88-4 is a valid CAS Registry Number.

92817-88-4Relevant articles and documents

Stereochemically versatile synthesis of the C1-C12 fragment of tedanolide c

Smith, Thomas E.,Fink, Sarah J.,Levine, Zebulon G.,McClelland, Kerani A.,Zackheim, Adrian A.,Daub, Mary E.

, p. 1452 - 1455 (2012)

A flexible synthesis of the C1-C12 fragment of Tedanolide C has been accomplished in eight steps from 2-methyl-2,4-pentadienal. Asymmetric hydroformylation of a 1,3-diene allows for the late-stage generation of either C10 epimer with complete catalyst con

Syntheses of Gymnothespirolignans B and C and Non-natural Isomer 9-Epi-gymnothespirolignan B

Ali, Ghada,Cuny, Gregory D.

, p. 10517 - 10525 (2021/07/31)

Syntheses of polycyclic spiro lignans gymnothespirolignans B and C as well as the unnatural isomer 9-epi-gymnothespirolignan B were accomplished using (R)-Roche ester and an appropriately substituted fluorenone. Key features of the convergent syntheses include coupling of the fluorenone and an iodo-alkene intermediate derived from (R)-Roche ester in the presence of the Lewis acid TiCl(OiPr)3, C9-O bond formation via an SN2 reaction with retention of stereochemistry, and diastereoselective hydrogenations of a common alkene intermediate guided by accessibility or positioning by the C8-methoxy.

The discovery and evaluation of 3-amino-2(1H)-pyrazinones as a novel series of selective p38α MAP kinase inhibitors

Evans, Richard,Raubo, Piotr,Willis, Paul

, (2020/07/21)

The discovery and optimisation of a novel series of potent and selective p38α inhibitors is described. Evaluating the structure-activity relationship of an aminoalkyl substituent at the 3 position of the 2(1H)-pyrazinone core, p38α potency was increased 20000-fold. The most advanced compound (25) demonstrated excellent in vivo properties suitable for an inhaled route of administration.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 92817-88-4